3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

| More on:
woman looking at iPhone whilst working on a laptop

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Pro Medicus shines as a top-tier choice with its robust business model, high margins, and the increasing global demand for its cutting-edge medical imaging technology.
  • REA Group's dominance as the go-to platform for property dealings and its smart diversification strategy position it well to capitalise on Australia's burgeoning digital services sector.
  • Temple & Webster is set to benefit from the shift towards online shopping, leveraging its efficient business model and market growth opportunities within the furniture sector.

Trying to predict what the share market will do next month or next year is a tough game. But looking a decade ahead is where long-term investors often gain a real edge.

Businesses with sustainable competitive advantages, long growth runways, and proven execution can compound shareholder value quietly over many years.

If you are prepared to buy quality and sit tight through market cycles, the rewards by 2035 could be substantial.

With that in mind, here are three Australian shares that tick those boxes and look well placed for long-term buy and hold investors.

Pro Medicus Ltd (ASX: PME)

Pro Medicus is arguably one of the ASX's highest-quality companies. It is the medical imaging software provider behind the Visage platform, which is used by leading hospitals and health networks across the United States.

What makes Pro Medicus especially attractive as a long-term holding is the strength of its business model. It operates with exceptionally high margins, recurring revenue, and minimal capital requirements. Once a hospital adopts its Visage platform, switching costs are high, and contract lengths are long.

With global demand for medical imaging continuing to rise due to radiologist shortages and digitisation still in its early stages, Pro Medicus has a long runway to expand earnings well beyond the next decade.

REA Group Ltd (ASX: REA)

REA Group is the company behind the realestate.com.au website. It has become the default destination for Australian property buyers, sellers, and agents, giving the company immense pricing power.

Even during softer housing markets, REA has continued to grow earnings by lifting yields from agents and expanding into adjacent services such as data, mortgages, and commercial property listings. This ability to grow without relying solely on listings volumes is a key reason it has been such a strong long-term performer.

Looking ahead to 2035, Australia's population growth, housing undersupply, and ongoing shift toward digital services suggest REA's competitive position is unlikely to weaken anytime soon. This bodes well for its earnings growth over the next decade.

Temple & Webster Group Ltd (ASX: TPW)

Finally, Temple & Webster may not yet have the scale of the other two, but its long-term potential is compelling. The online furniture and homewares retailer has steadily taken market share as consumers shift away from traditional bricks-and-mortar stores.

Its asset-light, digital-first model allows it to offer a wider product range, better data-driven marketing, and lower overheads than many competitors. Importantly, online penetration in furniture remains relatively low compared to categories like electronics or apparel, leaving plenty of room for growth.

If Temple & Webster continues to execute well, expands its private label offering, and benefits from the ongoing e-commerce tailwind, the next decade could be very positive.

Motley Fool contributor James Mickleboro has positions in Pro Medicus, REA Group, and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »